Pediatric Obesity: Clinical Trials

17 trials for Pediatric Obesity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed. 17 Phase 2, 4 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 217Completed 17
Phase 14Completed 4
Phase 32Completed 2

Follow Pediatric Obesity: new trials by email Literature Review of Pediatric Obesity trials Research Report on Pediatric Obesity

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Eat My ABCs Project
Eat My ABCs - Nutrition, Healthy, Obesity, Childhood
Phase 2 / Phase 3CompletedMichigan State University2022023-01-012024-06-07
Lifestyle Counseling and Medication for Adolescent Weight Management
Intensive Behavioral Program, Semaglutide and Behavioral Program - Obesity, Childhood
Phase 2CompletedUniversity of Minnesota1202022-03-152026-07-02
Causal Mechanisms in Adolescent Arterial Stiffness
CS+, CS- - Lipid Disorder, Dyslipidemias
Phase 2CompletedBaylor College of Medicine722020-02-012026-11-02
SMART Use of Medication for the Treatment of Adolescent Severe Obesity
Lifestyle Modification Therapy (LSMT), Phentermine Pill, Topiramate Pill - Adolescent Obesity
Phase 2CompletedUniversity of Minnesota1502019-11-212026-05-05
Treating PCOS With Semaglutide vs Active Lifestyle Intervention
Semaglutide 3mg and 7mg [Rybelsus], Weight loss diet - PCOS, Adolescent Obesity
Phase 2 / Phase 3CompletedUniversity of Colorado, Denver602019-05-032025-11-25
Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes
Aminohippurate Sodium Inj 20%, Iohexol Inj 300 mg/mL, Vertical Sleeve Gastrectomy - Type 2 Diabetes Mellitus, Obesity
Phase 1 / Phase 2CompletedUniversity of Colorado, Denver242018-10-012026-01-12
Endosleeve in Adolescents
Endoscopic Sleeve Gastroplasty - Obesity, Childhood
Phase 1 / Phase 2CompletedKing Saud University1002017-12-012019-05-07
The Effects of California Strawberries on Parameters of Cardiovascular Health
flavonoid-rich freeze-dried strawberry powder, macronutrient-matched control powder - Childhood Obesity, Cardiovascular Disease
Phase 2CompletedUniversity of California, Davis322012-05-012017-07-14
A Health Promotion Campaign Targeting Caregivers of Young Children
Take TIME Health Campaign - Childhood Obesity
Phase 2CompletedThe Hospital for Sick Children13742010-09-012013-08-27
Effect of Recombinant Human Growth Hormone (rhGH) on Abdominal Fat and Cardiovascular Risk in Obese Girls
recombinant human growth hormone (rhGH), Placebo - Obesity
Phase 2CompletedMassachusetts General Hospital222010-03-012021-11-02
Effect of Vitamin D3 Supplementation on Insulin Resistance and Cardiovascular Risk Factors in Obese Adolescents
Vitamin D3 - Obesity
Phase 2CompletedMayo Clinic512009-04-012014-05-20
Behavioral Rx & Nutrition in Pediatric Chronic Disease
LAUNCH, Pediatrician Counseling - Pediatric Obesity
Phase 1 / Phase 2CompletedChildren's Hospital Medical Center, Cincinnati182007-11-012009-11-23
Efficacy of Increasing Physical Activity to Reduce Children's Visceral Fat
Pediatric Obesity Intervention (STANDARD), Pediatric Obesity Intervention + High Activity (ADDED) - Obesity
Phase 1 / Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)292006-07-012010-03-02
IT-Supported Early Treatment Of Childhood Overweight
Telephone Linked Care-HEAT (TLC-HEAT) - Childhood Obesity, Technology Based Obesity Intervention
Phase 2CompletedBoston Medical Center2005-07-012010-08-25
Childhood Obesity: a Study of Group Treatment Targeting Parents Behaviour
Parent manualized group treatment, Parent self-help groups - Childhood Obesity
Phase 2CompletedNorwegian University of Science and Technology992004-10-012016-07-28
Metformin to Treat Obesity in Children With Insulin Resistance
Metformin HCL, Placebo - Hyperinsulinemia, Obesity
Phase 2CompletedJack Yanovski, M.D.1002000-05-012015-05-08
Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases
Orlistat, Placebo - Diabetes Mellitus, Hypertension
Phase 2CompletedJack Yanovski2001998-05-012012-12-18

Narrower conditions

Obesity (7)  ·  Insulin Resistance (4)  ·  Diabetes Mellitus (3)  ·  Dyslipidemias (3)  ·  Diabetes Mellitus, Type 2 (2)  ·  Body Weight (1)  ·  Cardiovascular Diseases (1)  ·  Diabetes Complications (1)  ·  Diabetic Nephropathies (1)  ·  Hyperinsulinism (1)  ·  Hypertension (1)  ·  Kidney Diseases (1)  ·  Lipid Metabolism Disorders (1)  ·  Metabolic Diseases (1)

Broader conditions

Nutrition Disorders (17)  ·  Nutritional and Metabolic Diseases (17)  ·  Overnutrition (17)  ·  Overweight (17)  ·  Pathological Conditions, Signs and Symptoms (17)  ·  Signs and Symptoms (17)  ·  Body Weight (16)  ·  Obesity (10)  ·  Glucose Metabolism Disorders (7)  ·  Metabolic Diseases (6)  ·  Hyperinsulinism (4)  ·  Endocrine System Diseases (3)  ·  Lipid Metabolism Disorders (2)  ·  Apnea (1)  ·  Behavior (1)

Interventions

semaglutide (2)  ·  Bariatric Surgery (1)  ·  Cholecalciferol (1)  ·  Diet, Reducing (1)  ·  Growth Hormone (1)  ·  Iohexol (1)  ·  Metformin (1)  ·  Orlistat (1)  ·  Phentermine (1)  ·  Spacecraft (1)  ·  Topiramate (1)  ·  p-Aminohippuric Acid (1)

Sponsors

University of Colorado, Denver (2)  ·  University of Minnesota (2)  ·  Baylor College of Medicine (1)  ·  Boston Medical Center (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Jack Yanovski (1)  ·  Jack Yanovski, M.D. (1)  ·  King Saud University (1)  ·  Massachusetts General Hospital (1)  ·  Mayo Clinic (1)  ·  Michigan State University (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  Norwegian University of Science and Technology (1)  ·  The Hospital for Sick Children (1)  ·  University of California, Davis (1)

Countries

United States (14)  ·  Canada (1)  ·  Norway (1)  ·  Saudi Arabia (1)

Top investigators

Aaron Kelly, PhD (1)  ·  Aayed R Alqahtani, MD FRCSC FACS (1)  ·  Brian E Saelens, Ph.D. (1)  ·  Brian McCrindle, MD (1)  ·  Claudia Fox, MD, MPH (1)  ·  Jack A Yanovski, M.D. (1)  ·  Jack A Yanovski, MD, PhD (1)  ·  Justin P Zachariah, MD MPH (1)  ·  Lori J Stark, Ph.D. (1)  ·  Madhusmita Misra, MD (1)  ·  Melanie Cree-Green, MD, PhD (1)  ·  Petter Bjornstad, MD (1)  ·  Ronnaug A Odegard, MD, PhD (1)  ·  Seema Kumar, M.D. (1)  ·  William Adams, MD (1)

Results publications

PMID 29718281, PMID 12105286, PMID 12126214, PMID 15112907, PMID 20528109, PMID 21228310, PMID 23388524, PMID 24251951, PMID 25435886, PMID 25483291, PMID 25644349, PMID 26210388, PMID 31658128, PMID 33059389, PMID 38271099, PMID 41349930, PMID 41475815, PMID 41708511, PMID 41978152, PMID 42014131

NIH funding

K24DK059492 (1), R01DK119456 (1), R01DK120612 (1), R01HL148217 (1), R21HD050939 (1), UL1RR024150 (1)